Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities.
Agache I, Antolin-Amerigo D, de Blay F, Boccabella C, Caruso C, Chanez P, Couto M, Covar R, Doan S, Fauquert JL, Gauvreau G, Gherasim A, Klimek L, Lemiere C, Nair P, Ojanguren I, Peden D, Perez-de-Llano L, Pfaar O, Rondon C, Rukhazde M, Sastre J, Schulze J, Silva D, Tarlo S, Toppila-Salmi S, Walusiak-Skorupa J, Zielen S, Eguiluz-Gracia I. Agache I, et al. Among authors: ojanguren i. Allergy. 2022 Jun;77(6):1667-1684. doi: 10.1111/all.15203. Epub 2022 Jan 20. Allergy. 2022. PMID: 34978085
Diagnosis of occupational hypersensitivity pneumonitis.
Morell F, Ojanguren I, Cruz MJ. Morell F, et al. Among authors: ojanguren i. Curr Opin Allergy Clin Immunol. 2019 Apr;19(2):105-110. doi: 10.1097/ACI.0000000000000511. Curr Opin Allergy Clin Immunol. 2019. PMID: 30649011 Review.
Impact of Low Dose Chlorine Inhalation in Healthy Humans: A Pilot Study.
Ojanguren I, Chaboillez S, Cloutier Y, Panariti A, McGovern TK, Martin JG, Lemiere C. Ojanguren I, et al. J Investig Allergol Clin Immunol. 2019;29(4):323-325. doi: 10.18176/jiaci.0396. Epub 2019 Apr 8. J Investig Allergol Clin Immunol. 2019. PMID: 30957763 Free article. No abstract available.
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score.
Pérez de Llano L, Dávila I, Martínez-Moragón E, Domínguez-Ortega J, Almonacid C, Colás C, García-Rivero JL, Carmona L, García de Yébenes MJ, Cosío BG; FEOS Study Group. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2725-2731. doi: 10.1016/j.jaip.2021.01.033. Epub 2021 Feb 4. J Allergy Clin Immunol Pract. 2021. PMID: 33549843
128 results